Devika R Jutagir1, Bonnie B Blomberg2,3, Charles S Carver1,2, Suzanne C Lechner2, Kiara R Timpano1, Laura C Bouchard1, Lisa M Gudenkauf1, Jamie M Jacobs4, Alain Diaz3, Susan K Lutgendorf5, Steve W Cole6, Aaron S Heller1,2, Michael H Antoni7,8. 1. Department of Psychology, University of Miami, 5665 Ponce De Leon Blvd., Coral Gables, FL, 33146, USA. 2. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Ave., Miami, FL, 33136, USA. 3. Department of Microbiology and Immunology, University of Miami Miller School of Medicine, 1600 NW 10th Ave., RMSB 3146A, Miami, FL, 33136, USA. 4. The Center for Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Yawkey Center for Outpatient Care, Suite 10B, Boston, MA, 02116, USA. 5. Department of Psychological and Brain Sciences, University of Iowa, E11 Seashore Hall, Iowa City, IA, 52242, USA. 6. Department of Medicine, UCLA School of Medicine, 11-934 Factor Building, Los Angeles, CA, 90095, USA. 7. Department of Psychology, University of Miami, 5665 Ponce De Leon Blvd., Coral Gables, FL, 33146, USA. mantoni@miami.edu. 8. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Ave., Miami, FL, 33136, USA. mantoni@miami.edu.
Abstract
PURPOSE: Satisfaction with social resources, or "social well-being," relates to better adaptation and longer survival after breast cancer diagnosis. Biobehavioral mechanisms linking social well-being (SWB) to mental and physical health may involve inflammatory signaling. We tested whether reports of greater SWB were associated with lower levels of pro-inflammatory and pro-metastatic leukocyte gene expression after surgery for non-metastatic breast cancer. METHODS: Women (N = 50) diagnosed with non-metastatic (0-III) breast cancer were enrolled 2-8 weeks after surgery. SWB was assessed with the social/family well-being subscale of the FACT-B. Leukocyte gene expression for specific pro-inflammatory (cytokines, chemokines, and COX-2) and pro-metastatic genes (e.g., MMP9) was derived from microarray analysis. RESULTS: Multiple regression analyses controlling for age, stage of disease, days since surgery, education, and body mass index (BMI) found higher levels of SWB related to less leukocyte pro-inflammatory and pro-metastatic gene expression (p < 0.05). Emotional well-being, physical well-being, and functional well-being did not relate to leukocyte gene expression (p > 0.05). Greater SWB remained significantly associated with less leukocyte pro-inflammatory and pro-metastatic gene expression after controlling for depressive symptoms. CONCLUSIONS: Results have implications for understanding mechanisms linking social resources to health-relevant biological processes in breast cancer patients undergoing primary treatment. CLINICAL TRIAL REGISTRATION NUMBER: NCT01422551.
PURPOSE: Satisfaction with social resources, or "social well-being," relates to better adaptation and longer survival after breast cancer diagnosis. Biobehavioral mechanisms linking social well-being (SWB) to mental and physical health may involve inflammatory signaling. We tested whether reports of greater SWB were associated with lower levels of pro-inflammatory and pro-metastatic leukocyte gene expression after surgery for non-metastatic breast cancer. METHODS:Women (N = 50) diagnosed with non-metastatic (0-III) breast cancer were enrolled 2-8 weeks after surgery. SWB was assessed with the social/family well-being subscale of the FACT-B. Leukocyte gene expression for specific pro-inflammatory (cytokines, chemokines, and COX-2) and pro-metastatic genes (e.g., MMP9) was derived from microarray analysis. RESULTS: Multiple regression analyses controlling for age, stage of disease, days since surgery, education, and body mass index (BMI) found higher levels of SWB related to less leukocyte pro-inflammatory and pro-metastatic gene expression (p < 0.05). Emotional well-being, physical well-being, and functional well-being did not relate to leukocyte gene expression (p > 0.05). Greater SWB remained significantly associated with less leukocyte pro-inflammatory and pro-metastatic gene expression after controlling for depressive symptoms. CONCLUSIONS: Results have implications for understanding mechanisms linking social resources to health-relevant biological processes in breast cancerpatients undergoing primary treatment. CLINICAL TRIAL REGISTRATION NUMBER: NCT01422551.
Entities:
Keywords:
Breast cancer; Inflammation; Leukocyte gene expression; Social support; Social well-being
Authors: Robert D Berahovich; Brian A Zabel; Susanna Lewén; Matthew J Walters; Karen Ebsworth; Yu Wang; Juan C Jaen; Thomas J Schall Journal: Immunology Date: 2014-01 Impact factor: 7.397
Authors: Dominique L Musselman; Wendy I Somerset; Ying Guo; Amita K Manatunga; Maryfrances Porter; Suzanne Penna; Barbara Lewison; Rebecca Goodkin; Kathryn Lawson; David Lawson; Dwight L Evans; Charles B Nemeroff Journal: J Clin Psychiatry Date: 2006-02 Impact factor: 4.384
Authors: M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood Journal: Clin Cancer Res Date: 2008-11-01 Impact factor: 12.531
Authors: Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin Journal: Brain Behav Immun Date: 2009-04-21 Impact factor: 7.217
Authors: Barbara L Fredrickson; Karen M Grewen; Kimberly A Coffey; Sara B Algoe; Ann M Firestine; Jesusa M G Arevalo; Jeffrey Ma; Steven W Cole Journal: Proc Natl Acad Sci U S A Date: 2013-07-29 Impact factor: 11.205
Authors: P Reynolds; P T Boyd; R S Blacklow; J S Jackson; R S Greenberg; D F Austin; V W Chen; B K Edwards Journal: Cancer Epidemiol Biomarkers Prev Date: 1994 Apr-May Impact factor: 4.254
Authors: Steven W Cole; Morgan E Levine; Jesusa M G Arevalo; Jeffrey Ma; David R Weir; Eileen M Crimmins Journal: Psychoneuroendocrinology Date: 2015-07-08 Impact factor: 4.905
Authors: Neha G Goyal; Beverly J Levine; Kimberly J Van Zee; Elizabeth Naftalis; Nancy E Avis Journal: Breast Cancer Res Treat Date: 2018-01-24 Impact factor: 4.872
Authors: Aeson Chang; Erica K Sloan; Michael H Antoni; Jennifer M Knight; Rachel Telles; Susan K Lutgendorf Journal: Integr Cancer Ther Date: 2022 Jan-Dec Impact factor: 3.077
Authors: Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole Journal: Cancer Date: 2017-11-07 Impact factor: 6.860
Authors: Danielle B Tometich; Kelly A Hyland; Hatem Soliman; Heather S L Jim; Laura Oswald Journal: Cancers (Basel) Date: 2020-12-08 Impact factor: 6.639
Authors: Deena S Goldwater; Mei Leng; Arun Karlamangla; Teresa Seeman; David Elashoff; Jonathan M Wanagat; David B Reuben; Brian R Lindman; Steve Cole Journal: BMC Cardiovasc Disord Date: 2021-08-02 Impact factor: 2.298